These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21327540)

  • 1. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors.
    Gupta P; Garg P; Roy N
    Mol Divers; 2011 Aug; 15(3):733-50. PubMed ID: 21327540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.
    Gupta P; Sharma A; Garg P; Roy N
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):141-50. PubMed ID: 23286784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
    Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
    Gupta P; Roy N; Garg P
    Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
    Bhatt H; Patel P; Pannecouque C
    Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
    Gupta P; Garg P; Roy N
    Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors.
    Yu S; Wang P; Li Y; Liu Y; Zhao G
    SAR QSAR Environ Res; 2013 Oct; 24(10):819-39. PubMed ID: 23988186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
    Guenther S; Nair V
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2233-6. PubMed ID: 12127545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
    Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
    PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
    Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
    Sharma H; Patil S; Sanchez TW; Neamati N; Schinazi RF; Buolamwini JK
    Bioorg Med Chem; 2011 Mar; 19(6):2030-45. PubMed ID: 21371895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.
    Savarino A
    Retrovirology; 2007 Mar; 4():21. PubMed ID: 17374162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site binding modes of curcumin in HIV-1 protease and integrase.
    Vajragupta O; Boonchoong P; Morris GM; Olson AJ
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3364-8. PubMed ID: 15950462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.